Gainers & Losers
Thu Mar 05 2026 09:55:57- Adani Ports and Special Ec...
- ₹1,495.754.29%
- Larsen & Toubro Ltd share price
- ₹4,019.003.53%
- NTPC share price
- ₹378.053.33%
- Bharat Electronics share price
- ₹460.903.18%
- Reliance Industries share price
- ₹1,387.103.09%
Active Stocks
Thu Mar 05 2026 10:11:10- Suzlon Energy share price
- ₹40.200.70%
- Oil and Natural Gas Corpor...
- ₹276.35-0.25%
- Eternal share price
- ₹240.30-0.17%
- Yes Bank share price
- ₹20.231.15%
- Tata Steel share price
- ₹200.602.01%
Business News/Market/Market Stats/GlaxoSmithKline Pharmaceuticals share price/ GlaxoSmithKline Pharmaceuticals Profit Loss Annual
GlaxoSmithKline Pharmaceuticals Profit & Loss Annual
2,478.10 -4.30 (-0.17%)Updated : 05 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 2,634.86 | 2,778.00 | 2,513.91 | 2,599.03 |
| Other Net | 4.77 | 4.85 | -0.37 | 3.45 |
| Diluted Weighted Average Shares | 16.94 | 16.94 | 16.94 | 16.94 |
| Gain( Loss)on Saleof Assets | 3.18 | 20.58 | 9.67 | 31.72 |
| Depreciation/ Amortization | 66.66 | 69.54 | 65.62 | 68.04 |
| Operating Income | 1,114.35 | 675.71 | 737.81 | 679.00 |
| Net Income | 927.58 | 589.96 | 610.69 | 1,694.72 |
| Income Availableto Com Excl Extra Ord | 927.58 | 589.96 | 607.64 | 380.77 |
| Other Operating Expenses Total | 60.64 | 61.01 | 52.24 | 47.06 |
| Net Income Before Taxes | 1,259.88 | 816.19 | 836.40 | 779.05 |
| Interest Exp( Inc) Net- Operating Total | 0.13 | 0.14 | 0.14 | 0.14 |
| Net Income After Taxes | 927.58 | 589.96 | 607.64 | 380.77 |
| Income Availableto Com Incl Extra Ord | 927.58 | 589.96 | 610.69 | 1,694.72 |
| Costof Revenue Total | 1,512.30 | 1,457.10 | 1,394.28 | 1,482.14 |
| Gross Profit | 2,236.91 | 1,996.61 | 1,857.44 | 1,795.89 |
| Interest Inc( Exp) Net- Non- Op Total | 137.58 | 115.05 | 89.29 | 64.87 |
| Diluted Net Income | 927.58 | 589.96 | 610.69 | 1,694.72 |
| DPS- Common Stock Primary Issue | 42.00 | 32.00 | 32.00 | 30.00 |
| Provisionfor Income Taxes | 332.30 | 226.23 | 228.76 | 398.28 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 927.58 | 589.96 | 607.64 | 380.77 |
| Total Revenue | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 |
| Selling/ General/ Admin Expenses Total | 995.12 | 1,026.91 | 991.00 | 981.81 |
| Diluted Normalized EPS | 54.62 | 40.92 | 35.91 | 22.13 |
| Diluted EPS Excluding Extra Ord Items | 54.76 | 34.83 | 35.87 | 22.48 |
| Total Extraordinary Items | - | 0.00 | 3.04 | 1,313.95 |
| Unusual Expense( Income) | - | 163.30 | 10.61 | 19.82 |
*All figures in crores except per share values
GlaxoSmithKline Pharmaceuticals Quick Links
GlaxoSmithKline Pharmaceuticals Dividend GlaxoSmithKline Pharmaceuticals Bonus GlaxoSmithKline Pharmaceuticals News GlaxoSmithKline Pharmaceuticals AGM GlaxoSmithKline Pharmaceuticals Rights GlaxoSmithKline Pharmaceuticals Splits GlaxoSmithKline Pharmaceuticals Board Meetings GlaxoSmithKline Pharmaceuticals Key Metrics GlaxoSmithKline Pharmaceuticals Shareholdings GlaxoSmithKline Pharmaceuticals Balance Sheet GlaxoSmithKline Pharmaceuticals Cashflow GlaxoSmithKline Pharmaceuticals Q1 Results GlaxoSmithKline Pharmaceuticals Q2 Results GlaxoSmithKline Pharmaceuticals Q3 Results GlaxoSmithKline Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
382.75+7.30(1.94%)
2,359.30+14.45(0.62%)
209.15+1.10(0.53%)
1,346.55-95.20 (-6.60%)
1,339.40-86.95 (-6.10%)